Tag Archive for: genetics

Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer

/in

Brings deep expertise in immunology, oncology and pharmacology with a strong track record of advancing innovative pipelines through discovery and translation into the clinic Reflects growing momentum at Nucleome following nomination of first preclinical development candidate for lead candidate NTP464, which is progressing towards IND enabling studies  Oxford, UK, 16 February 2026 – Nucleome Therapeutics […]

Read more

Nucleome Therapeutics nominates first preclinical development candidate

/in

First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic inflammatory diseases Evolution of Nucleome’s non-coding genetics platform reveals further groundbreaking insights into disease areas of high unmet need Oxford, UK, 07 January 2026 – Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a company tackling the molecular causes of inflammatory diseases through […]

Read more

Nucleome Therapeutics appoints Bhavna Hunjan as Chief Business Officer

/in

Oxford, UK, 27 May 2025 – Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, announces it has appointed Bhavna Hunjan as Chief Business Officer with immediate effect. Read more…

Read more

Hot topic: Questions emerge about bioethics as reports suggest 23 and Me faces takeover

/in

The catastrophic fall from grace of the genetic testing app 23 and Me is a salutary lesson for all companies that espouse the use of “big data” in healthcare.  Once a leading digital health tech firm, worth $6 billion as recently as 2021, the company is now on the verge of being taken private at […]

Read more

Optimum’s hot topic: Can we ‘bottle’ the remarkable biology of people who, against all odds, beat killer diseases?

/in

By Stephen Adams, Optimum Strategic Communications   Nature has been an inspiration behind the development of many drugs, starting with the humble aspirin, which was originally derived from willow bark.  But what if we could learn the secrets of what gives some people the incredible ability to overcome the most serious diseases?  What if we could […]

Read more